Review
BibTex RIS Cite

COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI

Year 2021, Volume: 6 Issue: 2, 24 - 32, 31.07.2021

Burcu Ertit Taştan Ebru Beyzi Bahtiyar Bakır

https://doi.org/10.52881/gsbdergi.826411
Cited By: 1

Abstract

Aralık 2019'da ortaya çıkan ve tüm dünyada salgına neden olan COVID-19, başta sağlık, psikoloji ve ekonomi olmak üzere birçok alanda olumsuz etkilere sebep olmuştur. Bu virüs, temas ve damlacıklar yoluyla çok kısa sürede birçok insanı enfekte etmiştir. Virüse karşı bir aşı henüz ortaya çıkmamıştır ancak sosyal mesafe ile virüsü önlemek mümkündür. Dünyanın dört bir yanına bakıldığında her ülke, farklı zamanlarda farklı önlemler alarak virüsün yayılmasını azaltmaya çalışmaktadır. Salgın devam ederken, COVID-19'a yönelik tedavi stratejileri ve önlemleri daha iyi anlamak için birçok araştırma yayınlanmaya devam etmektedir. Bu makale, eşit nüfusa sahip ülkelerdeki COVID-19 vakalarının sayısını incelemekte ve Türkiye, İran ve Almanya’da virüse karşı alınan önlemler ülkeler bazında değerlendirilmektedir.

Keywords

COVID-19 Almanya İran Türkiye pandemi

References

  • Referans1 WHO a. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19whoint/. 2020a.
  • Referans2 Huang C, Wang Y, Li X, Ren, L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
  • Referans3 Zhu N, Zhang DY, Wang WL, Li XW, Yang B, Song JD, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New Engl J Med. 2020; 382(8): 727-733.
  • Referans4 Lai MMC, Perlman S, Anderson JL. Coronaviridae. Fields Virology, 5th edition Philadelphia: Lippincott Williams & Wilkins. 2006; 1305–1335.
  • Referans5 Chen B, Tian EK, He B, Tian LJ, Han RY, Wang SW, et al. Overview of lethal human coronaviruses. Signal Transduct Tar. 2020; 5(1): 89.
  • Referans6 Dijkman R, van der Hoek L. Human Coronaviruses 229E and NL63: Close Yet Still So Far. J Formos Med Assoc. 2009; 108(4): 270-279.
  • Referans7 WHO b. Novel Coronavirus – Thailand (ex-China). 2020b. https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand-ex-china/en/ Erişim tarihi 15.11.2020
  • Referans8 Duffey RB, Zio E. Prediction of COVID-19 infection, transmission and recovery rates: A new analysis and global societal comparisons. Safety Sci. 2020; 129: 104854.
  • Referans9 WHO c. Q&A on coronaviruses (COVID-19). 2020c. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-coronaviruses. Erişim tarihi 15.11.2020
  • Referans10 Carraturo F, Del Giudice C, Moreli M, Cerullo V, Libralato G, Galdiero E, et al. Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces. Environ Pollut. 2020; 265: 115010.
  • Referans11 Shahriarirad R, Khodamoradi Z, Erfani A, Hosseinpour H, Ranjbar K, Emami Y, et al. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. Bmc Infect Dis. 2020; 20(1): 427.
  • Referans12 Rahimzadeh G, Noghabi ME, Elyaderani FK, Navaeifar MR, Enayati AA, Anari AM, et al. COVID-19 Infection in Iranian Children: A Case Series of 9 Patients. J Pediat Rev. 2020; 8(2): 139-144.
  • Referans13 Korkmaz MF, Ture E, Dorum BA, Kilic ZB. The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study. J Korean Med Sci. 2020; 35(25): e236.
  • Referans14 Selim M, Mohamed S, Abdo M, Abdelhaffez A. Is COVID-19 Similar in Pregnant and Non-Pregnant Women? Cureus. 2020; 12(6): e8888.
  • Referans15 London V, McLaren R, Atallah F, Cepeda C, McCalla S, Fisher N, et al. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19. Am J Perinat. 2020; 37(10): 991-994.
  • Referans16 T.C Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü COVID-19 Genel Bilgiler, Epidemioloji ve Tanı, Bilimsel Danışma Kurulu Çalışması 30 May 2020.
  • Referans17 United States Centers for Disease Control and Prevention (CDC) Interim guidance for businesses and employers. Plan, prepare and respond to coronavirus disease 2019. https://www.cdc.gov/coronavirus/2019-ncov/community/guidance-business-response.html Erişim tarihi 15.11.2020
  • Referans18 Parmet WE, Sinha MS. COVID-19-The Law and Limits of Quarantine. New Engl J Med. 2020; 382(15): e28.
  • Referans19 Türkiye İstatistik Kurumu Sağlık personeli sayısı, 1928-2018. https://data.tuik.gov.tr/Kategori/GetKategori?p=saglik-ve-sosyal-koruma-101&dil=1 Erişim tarihi 15.11.2020
  • Referans20 T.C Sağlık Bakanlığı COVID-19 haftalık durum raporu 19.10.2020-25.10.2020 https://covid19.saglik.gov.tr/Eklenti/39229/0/covid-19-haftalik-durum-raporu---43pdf.pdf?_tag1=70F7CD89B8F7191D8FAD3ACF29EF550190C31B61. Erişim tarihi 15.11.2020
  • Referans21 Statista. https://www.statista.com/statistics/1105523/coronavirus-covid-19-symptoms-most-frequent-germany/. 2020. Erişim tarihi 15.09.2020.
  • Referans22 Bauer A, Weber E. COVID-19: how much unemployment was caused by the shutdown in Germany? Applied Economics Letters. 2020; https://doi.org/10.1080/13504851.2020.1789544.
  • Referans23 Tastan C, Yurtsever B, Karakus GS, Kancagi DD, Demir S, Abanuz S, et al. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients. Turk J Biol. 2020; 44(3): 192-202.
  • Referans24 Sahin M. Impact of weather on COVID-19 pandemic in Turkey. Sci Total Environ. 2020; 728: 138810.
  • Referans25 Ahmadi M, Sharifi A, Dorosti S, Ghoushchi SJ, Ghanbari N. Investigation of effective climatology parameters on COVID-19 outbreak in Iran. Sci Total Environ. 2020; 729: 138705.
  • Referans26 Stafford N. Covid-19: Why Germany's case fatality rate seems so low. Bmj-Brit Med J. 2020;369.
  • Referans27 Jafari H, Gharaghani MA. Cultural Challenges: The Most Important Challenge of COVID-19 Control Policies in Iran. Prehosp Disaster Med. 2020; 35(4): 470-471.
  • Referans28 Raoofi A, Takian A, Sari AA, Olyaeemanesh A, Haghighi H, Aarabi M. COVID-19 Pandemic and Comparative Health Policy Learning in Iran. Arch Iran Med. 2020; 23(4): 220-234.
  • Referans29 Reza G, Fatemeh H. COVID-19 and Iran: swimming with hands tied! Swiss Med Wkly. 2020;150.
  • Referans30 Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems. Infect Cont Hosp Ep. 2020; 41(6): 754-755.
  • Referans31 Schartau P, Kirby M. Male mortality and the German response: lessons from COVID-19. Trend Urol Mens Heal. 2020; 11(3): 26-28.

Year 2021, Volume: 6 Issue: 2, 24 - 32, 31.07.2021

Burcu Ertit Taştan Ebru Beyzi Bahtiyar Bakır

https://doi.org/10.52881/gsbdergi.826411
Cited By: 1

Abstract

References

  • Referans1 WHO a. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19whoint/. 2020a.
  • Referans2 Huang C, Wang Y, Li X, Ren, L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
  • Referans3 Zhu N, Zhang DY, Wang WL, Li XW, Yang B, Song JD, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New Engl J Med. 2020; 382(8): 727-733.
  • Referans4 Lai MMC, Perlman S, Anderson JL. Coronaviridae. Fields Virology, 5th edition Philadelphia: Lippincott Williams & Wilkins. 2006; 1305–1335.
  • Referans5 Chen B, Tian EK, He B, Tian LJ, Han RY, Wang SW, et al. Overview of lethal human coronaviruses. Signal Transduct Tar. 2020; 5(1): 89.
  • Referans6 Dijkman R, van der Hoek L. Human Coronaviruses 229E and NL63: Close Yet Still So Far. J Formos Med Assoc. 2009; 108(4): 270-279.
  • Referans7 WHO b. Novel Coronavirus – Thailand (ex-China). 2020b. https://www.who.int/csr/don/14-january-2020-novel-coronavirus-thailand-ex-china/en/ Erişim tarihi 15.11.2020
  • Referans8 Duffey RB, Zio E. Prediction of COVID-19 infection, transmission and recovery rates: A new analysis and global societal comparisons. Safety Sci. 2020; 129: 104854.
  • Referans9 WHO c. Q&A on coronaviruses (COVID-19). 2020c. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-coronaviruses. Erişim tarihi 15.11.2020
  • Referans10 Carraturo F, Del Giudice C, Moreli M, Cerullo V, Libralato G, Galdiero E, et al. Persistence of SARS-CoV-2 in the environment and COVID-19 transmission risk from environmental matrices and surfaces. Environ Pollut. 2020; 265: 115010.
  • Referans11 Shahriarirad R, Khodamoradi Z, Erfani A, Hosseinpour H, Ranjbar K, Emami Y, et al. Epidemiological and clinical features of 2019 novel coronavirus diseases (COVID-19) in the South of Iran. Bmc Infect Dis. 2020; 20(1): 427.
  • Referans12 Rahimzadeh G, Noghabi ME, Elyaderani FK, Navaeifar MR, Enayati AA, Anari AM, et al. COVID-19 Infection in Iranian Children: A Case Series of 9 Patients. J Pediat Rev. 2020; 8(2): 139-144.
  • Referans13 Korkmaz MF, Ture E, Dorum BA, Kilic ZB. The Epidemiological and Clinical Characteristics of 81 Children with COVID-19 in a Pandemic Hospital in Turkey: an Observational Cohort Study. J Korean Med Sci. 2020; 35(25): e236.
  • Referans14 Selim M, Mohamed S, Abdo M, Abdelhaffez A. Is COVID-19 Similar in Pregnant and Non-Pregnant Women? Cureus. 2020; 12(6): e8888.
  • Referans15 London V, McLaren R, Atallah F, Cepeda C, McCalla S, Fisher N, et al. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19. Am J Perinat. 2020; 37(10): 991-994.
  • Referans16 T.C Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü COVID-19 Genel Bilgiler, Epidemioloji ve Tanı, Bilimsel Danışma Kurulu Çalışması 30 May 2020.
  • Referans17 United States Centers for Disease Control and Prevention (CDC) Interim guidance for businesses and employers. Plan, prepare and respond to coronavirus disease 2019. https://www.cdc.gov/coronavirus/2019-ncov/community/guidance-business-response.html Erişim tarihi 15.11.2020
  • Referans18 Parmet WE, Sinha MS. COVID-19-The Law and Limits of Quarantine. New Engl J Med. 2020; 382(15): e28.
  • Referans19 Türkiye İstatistik Kurumu Sağlık personeli sayısı, 1928-2018. https://data.tuik.gov.tr/Kategori/GetKategori?p=saglik-ve-sosyal-koruma-101&dil=1 Erişim tarihi 15.11.2020
  • Referans20 T.C Sağlık Bakanlığı COVID-19 haftalık durum raporu 19.10.2020-25.10.2020 https://covid19.saglik.gov.tr/Eklenti/39229/0/covid-19-haftalik-durum-raporu---43pdf.pdf?_tag1=70F7CD89B8F7191D8FAD3ACF29EF550190C31B61. Erişim tarihi 15.11.2020
  • Referans21 Statista. https://www.statista.com/statistics/1105523/coronavirus-covid-19-symptoms-most-frequent-germany/. 2020. Erişim tarihi 15.09.2020.
  • Referans22 Bauer A, Weber E. COVID-19: how much unemployment was caused by the shutdown in Germany? Applied Economics Letters. 2020; https://doi.org/10.1080/13504851.2020.1789544.
  • Referans23 Tastan C, Yurtsever B, Karakus GS, Kancagi DD, Demir S, Abanuz S, et al. SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients. Turk J Biol. 2020; 44(3): 192-202.
  • Referans24 Sahin M. Impact of weather on COVID-19 pandemic in Turkey. Sci Total Environ. 2020; 728: 138810.
  • Referans25 Ahmadi M, Sharifi A, Dorosti S, Ghoushchi SJ, Ghanbari N. Investigation of effective climatology parameters on COVID-19 outbreak in Iran. Sci Total Environ. 2020; 729: 138705.
  • Referans26 Stafford N. Covid-19: Why Germany's case fatality rate seems so low. Bmj-Brit Med J. 2020;369.
  • Referans27 Jafari H, Gharaghani MA. Cultural Challenges: The Most Important Challenge of COVID-19 Control Policies in Iran. Prehosp Disaster Med. 2020; 35(4): 470-471.
  • Referans28 Raoofi A, Takian A, Sari AA, Olyaeemanesh A, Haghighi H, Aarabi M. COVID-19 Pandemic and Comparative Health Policy Learning in Iran. Arch Iran Med. 2020; 23(4): 220-234.
  • Referans29 Reza G, Fatemeh H. COVID-19 and Iran: swimming with hands tied! Swiss Med Wkly. 2020;150.
  • Referans30 Abdi M. Coronavirus disease 2019 (COVID-19) outbreak in Iran: Actions and problems. Infect Cont Hosp Ep. 2020; 41(6): 754-755.
  • Referans31 Schartau P, Kirby M. Male mortality and the German response: lessons from COVID-19. Trend Urol Mens Heal. 2020; 11(3): 26-28.
There are 31 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Makaleler
Authors

Burcu Ertit Taştan

Ebru Beyzi

Bahtiyar Bakır

Publication Date July 31, 2021
Submission Date January 22, 2021
Acceptance Date May 20, 2021
Published in Issue Year 2021 Volume: 6 Issue: 2

Cite

APA Ertit Taştan, B., Beyzi, E., & Bakır, B. (2021). COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI. Gazi Sağlık Bilimleri Dergisi, 6(2), 24-32. https://doi.org/10.52881/gsbdergi.826411
AMA Ertit Taştan B, Beyzi E, Bakır B. COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI. Gazi sağlık bilim. derg. July 2021;6(2):24-32. doi:10.52881/gsbdergi.826411
Chicago Ertit Taştan, Burcu, Ebru Beyzi, and Bahtiyar Bakır. “COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI”. Gazi Sağlık Bilimleri Dergisi 6, no. 2 (July 2021): 24-32. https://doi.org/10.52881/gsbdergi.826411.
EndNote Ertit Taştan B, Beyzi E, Bakır B (July 1, 2021) COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI. Gazi Sağlık Bilimleri Dergisi 6 2 24–32.
IEEE B. Ertit Taştan, E. Beyzi, and B. Bakır, “COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI”, Gazi sağlık bilim. derg, vol. 6, no. 2, pp. 24–32, 2021, doi: 10.52881/gsbdergi.826411.
ISNAD Ertit Taştan, Burcu et al. “COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI”. Gazi Sağlık Bilimleri Dergisi 6/2 (July 2021), 24-32. https://doi.org/10.52881/gsbdergi.826411.
JAMA Ertit Taştan B, Beyzi E, Bakır B. COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI. Gazi sağlık bilim. derg. 2021;6:24–32.
MLA Ertit Taştan, Burcu et al. “COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI”. Gazi Sağlık Bilimleri Dergisi, vol. 6, no. 2, 2021, pp. 24-32, doi:10.52881/gsbdergi.826411.
Vancouver Ertit Taştan B, Beyzi E, Bakır B. COVID-19 PANDEMİSİ VE EŞ NUFUSLU ÜLKELERİN DURUM KIYASLAMASI. Gazi sağlık bilim. derg. 2021;6(2):24-32.

Cited By

Comparative Analysis of Covid-19 Government Strategies in Argentina, Brazil, India, Pakistan, and Turkey
OPUS Toplum Araştırmaları Dergisi
https://doi.org/10.26466/opusjsr.1060281